LumiThera, Inc. is an ophthalmic medical device company that is harnessing the power of light to diagnose, treat, and monitor ocular disease and damage including dry age-related macular degeneration (AMD). LumiThera is at the forefront of ophthalmic photobiomodulation development with its flagship product, the multiwavelength Valeda® Light Delivery System. Valeda offers a brighter horizon for patients suffering from dry AMD. Valeda is CE Marked in the EU and is available in select countries in Latin America. Valeda is not cleared by the Food & Drug Administration (FDA). AdaptDx Pro® Dark Adaptometer allows detection of AMD three years before clinical presentation. AdaptDx Pro is listed on the FDA’s Establishment Registration & Device Listing. Diopsys ERG and VEP Vision Testing System is a comprehensive electrophysiology platform that provides a clear and objective view of the entire pathway for visual and neuro-visual disorders. VEP is FDA-cleared. ERG and VEP are available in select countries outside of the USA. LumiThera’s AMD Excellence Program® provides customer implementation, training, and ongoing support across all brands. For more information on Valeda, visit www.lumithera.com. AdaptDx Pro and Diopsys are available separately through LumiThera Diagnostics, Inc. and Diopsys, Inc.